Wanted: More Women to Become Financial Planners
A $12,000 Smartphone May Already Be in Your Pocket
Amazon to Turn Fan Fiction into a Money Maker with Kindle Worlds
NASDAQ: ASTM
Aastrom Biosciences Appoints Daniel Orlando As Chief Commercial Officer
Aastrom Biosciences Appoints Daniel R. Orlando as Chief Commercial Officer
Biotech Industry Merger and Acquisition Activity at a Four-Year High
Healthcare Sector: New 52-week Highs And Lows On Aug.20
Aastrom downgraded to Neutral from Buy at Roth Capital
Aastrom Biosciences' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aastrom reports Q2 EPS (22c), consensus (24c)
Aastrom Biosciences Reports Operating Results for the Quarter and Six Months Ended June 30, 2012
Aastrom to Host Second Quarter 2012 Investor Call on August 7, 2012
Aastrom Announces Results of Common Stock Exchange for December 2010 Warrants